Clinical Trial Update: A Study of DM001 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating DM001 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• DM001

Snippet

Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd. | Conditions: Breast Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: RECRUITING